TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/10/14 18:30 | 11/10/14 | PCYC | Pharmacyclics Inc | DE | Health | Drug | Pharmaceutical Preparations | Love Richard B | CA | O | GC | M.d | 49 | 32.38 | 0 | 2 | 0 | D | |||||||||||||||
11/10/14 18:30 | 11/10/14 | PCYC | Pharmacyclics Inc | DE | Health | Drug | Pharmaceutical Preparations | Love Richard B | CA | O | GC | S.d | -201 | 133.87 | 0 | -2 | -88 | 0 | D | ||||||||||||||
8/28/14 21:52 | 8/27/14 | PCYC | Pharmacyclics Inc | DE | Health | Drug | Pharmaceutical Preparations | Love Richard B | CA | O | GC | M.d | 49 | 32.38 | 0 | 2 | 0 | D | |||||||||||||||
8/28/14 21:52 | 8/27/14 | PCYC | Pharmacyclics Inc | DE | Health | Drug | Pharmaceutical Preparations | Love Richard B | CA | O | GC | S.d | -186 | 124.00 | 0 | -2 | -88 | 0 | D | ||||||||||||||
5/31/13 20:03 | 5/31/13 | PCYC | Pharmacyclics Inc | DE | Health | Drug | Pharmaceutical Preparations | Love Richard B | CA | O | VP,GC | M.d | 259 | 32.38 | 0 | 8 | 0 | D | |||||||||||||||
5/31/13 20:03 | 5/31/13 | PCYC | Pharmacyclics Inc | DE | Health | Drug | Pharmaceutical Preparations | Love Richard B | CA | O | VP,GC | S.d | -712 | 89.00 | 0 | -8 | -100 | 0 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |